# MIDAZOLAM IN 0.9% SODIUM CHLORIDE
> **ANDA216159** · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2023-04-17
## Drug
- **FDA Application Number:** ANDA216159
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MIDAZOLAM IN 0.9% SODIUM CHLORIDE
- **Generic name:** MIDAZOLAM IN SODIUM CHLORIDE
- **Active ingredients:** MIDAZOLAM
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** HIKMA
- **Manufacturer:** Hikma Pharmaceuticals USA Inc.
- **First approval:** 2023-04-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216159)
---
*AI Analytics · CC0 1.0*